000 | 01306 a2200361 4500 | ||
---|---|---|---|
005 | 20250514033631.0 | ||
264 | 0 | _c20030507 | |
008 | 200305s 0 0 eng d | ||
022 | _a1465-6566 | ||
024 | 7 |
_a10.1517/14656566.3.6.755 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMekhail, Tarek M | |
245 | 0 | 0 |
_aPaclitaxel in cancer therapy. _h[electronic resource] |
260 |
_bExpert opinion on pharmacotherapy _cJun 2002 |
||
300 |
_a755-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
700 | 1 | _aMarkman, Maurie | |
773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 3 _gno. 6 _gp. 755-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.3.6.755 _zAvailable from publisher's website |
999 |
_c11933664 _d11933664 |